You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
Researchers will study how prior hypoglycemic episodes can result in the "metabolic memory" of persistent vascular complications.
The funds will be used to expand the PharmGKB database and support the activities of the Clinical Pharmacogenetics Implementation Consortium.
Vanderbilt received the grant from NIGMS to establish a new personalized medicine and pharmacogenomics research center.
The funds will support efforts to develop novel data compression strategies for handling various kinds of genomic data.
In addition to a significant increase in NIH's annual funding, the legislation would provide $10 billion over five years for an NIH Innovation Fund.
The recipients of the funding will develop tools to identify certain pathogens often implicated in infections in healthcare settings.
UC Davis' Simeon Boyd and his colleagues will continue genetic research into the condition to identify biomarkers, which could be used for early detection and treatment.
The database will be used to research new technologies and treatments, as well as to track the health outcomes of children with rare genetic disorders.
The award from the NIH will go toward development of a test for detecting common bacteria from blood with an initial focus on carbepenem-resistant Enterobacteriaceae.
The database has received a total of $35 million in funding, and in 2014 more than 180,000 scientists accessed it for their research.
The Wall Street Journal reports that Russia's announcement of a coronavirus vaccine approval was met with concern as safety testing has not yet been completed.
New Scientist writes there aren't much data available on the accuracy of the two rapid COVID-19 tests the UK plans to roll out.
In PNAS this week: downstream effect of oncoprotein fusion, epigenetic changes influence tRNAs in colon cancer, and more.
Nature News reports that recent proposed changes to the US National Science Foundation have raised concerns about a shift away from the agency's focus on basic research.